16 The agencies pointed out 17 that commenters also noted that enabling States to more easily and, perhaps, therefore, more frequently, update their EHB-benchmark plans could result in expanded coverage for, among other things, maternity care, substance use disorder care, obesity care, and chronic disease management. So while most current EHB benchmark plans do not include coverage for anti-obesity medications, that could certainly change in the coming years
Muta Y, Kobayashi K, Toyoda M, et al
Even so, moving from this biochemical function to clinical outcomes is not always straightforward: the evidence can be heterogeneous and depends on dose, duration, the population studied and lifestyle variables
Patients with a history of substance abuse are at elevated risk for psychological dependence, and this risk does not disappear simply because a GLP-1 medication is being taken simultaneously
Zinc modulates cytokine-induced lung epithelial cell barrier permeability